News | Mammography | November 21, 2018

Volpara Solutions Showcases Latest VolparaEnterprise Software Tools at RSNA

Company will show off cloud-based quantitative breast imaging analysis tools, host speaker series

Volpara Solutions Showcases Latest VolparaEnterprise Software Tools at RSNA

November 21, 2018 — Volpara Solutions Inc. will showcase its latest artificial intelligence (AI) updates at the 104th Annual Radiological Society of North America (RSNA) meeting, Nov. 25–30 in Chicago. Its suite of cloud-based quantitative breast imaging analysis tools is designed to help maintain consistent quality in breast screening.

This year, Volpara will launch the VolparaLive! system, mammography's first real-time decision support system at the point of care. The VolparaLive! system automatically analyzes patient positioning and compression to help technologists acquire consistent, high-quality mammograms. One of the key benefits of the system is the cost reduction of fewer technical recalls, made possible by providing technologists with actionable data before the patient leaves the room.

Major improvements to the VolparaEnterprise software will be demonstrated for the first time:

  • A new reporting function for periodic image quality reviews further streamlines Enhancing Quality Using the Inspection Program (EQUIP) compliance and the image quality review process;
  • Users can generate a list of exams based on the VolparaEnterprise quality assessment for periodic image quality reviews, sorting by interpreting physicians and technologists; and
  • The software now features vPGMI, a new image positioning quality standard, according to Volpara.

This year, Volpara will host a distinguished speaker series at RSNA, including:

  • Prof. Jack Cuzick: Volpara and Risk Assessment: Importance of Volumetric Density in TC8
    • Director, Wolfson Institute of Preventive Medicine; Head, Centre for Cancer Prevention and John Snow Professor of Epidemiology, Queen Mary University of London
  • JoAnn Pushkin: Breast Density Legislation and Education – US and Europe
    • Executive Director, DenseBreast-Info.org
  • Prof. Sir Mike Brady: How AI and Machine Learning Can Impact Mammography
    • Professor of Oncological Imaging, University of Oxford
  • Amy Chatten, MPH, Measuring the Impact of Hands-On Technologist Training on Mammographic Image Quality
    • Executive Director, Mammography Educators, LLC

 

For more information: www.volparasolutions.com

Related Content

Novel Coronavirus SARS-CoV-2 Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: National Institute of Allergy and Infectious Diseases, NIH

Novel Coronavirus SARS-CoV-2 Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Image courtesy of  National Institute of Allergy and Infectious Diseases (NIH)

News | Coronavirus (COVID-19) | January 15, 2021
January 15, 2021 — In one of the first studies to examine the impact of the...
A, Contrast-enhanced axial T1-weighted fat-saturated image from baseline MRI before initiation of neoadjuvant therapy shows irregular mass (arrow) in upper inner right breast corresponding to biopsy-proven carcinoma. B, Contrast-enhanced axial T1-weighted fat-saturated image from follow-up MRI performed 3 months after initiation of neoadjuvant therapy shows decrease in size of right breast cancer (arrow). C, Contrast-enhanced axial T1-weighted fat-saturated image 3 months after initiation of neoadjuvant the

A, Contrast-enhanced axial T1-weighted fat-saturated image from baseline MRI before initiation of neoadjuvant therapy shows irregular mass (arrow) in upper inner right breast corresponding to biopsy-proven carcinoma. B, Contrast-enhanced axial T1-weighted fat-saturated image from follow-up MRI performed 3 months after initiation of neoadjuvant therapy shows decrease in size of right breast cancer (arrow). C, Contrast-enhanced axial T1-weighted fat-saturated image 3 months after initiation of neoadjuvant therapy shows new mass (arrow) in upper outer left breast that was assessed as BI-RADS 4. Pathologic examination from MRI-guided core biopsy of new suspicious mass revealed benign usual ductal hyperplasia. No atypia or malignancy was identified. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | MRI Breast | January 15, 2021
January 15, 2021 — According to ARRS' ...
A targeted intervention providing mammograms to hospitalized Medicaid patients can help patients complete overdue breast cancer screening

Getty Images

News | Mammography | January 14, 2021
January 14, 2021 — Completing cancer screening tests, such as...
DB-I website features new educational tools and streamlined user experience to improve access to medically sourced breast density content
News | Breast Density | January 13, 2021
January 13, 2021 — DenseBreast-info.org (DB-I) invites he
This cutting-edge technology assists radiologists in the interpretation of screening mammograms and allows them to diagnose breast cancer earlier and more accurately
News | Mammography | January 12, 2021
January 12, 2021 — Therapixel announced that...
The U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach to advance the Agency's oversight of AI/ML-based medical software.
News | Artificial Intelligence | January 12, 2021
January 12, 2021 — The U.S.
World-first techniques for predicting breast cancer risk from mammograms that were developed in Melbourne could revolutionise breast screening by allowing it to be tailored to women at minimal extra cost

Getty Images

News | Mammography | January 06, 2021
January 6, 2021 — World-first techniques for predicting breast cancer risk from...
Transaction accelerates Hologic’s entry into oncology growth market, provides new lab capabilities

Getty Images

News | Breast Imaging | January 06, 2021
January 6, 2021 — Hologic, Inc., a global leader in women's...